The new 72,500-square-foot building increases the site’s chemistry, manufacturing and control (CMC) analytical capabilities.
The PPD clinical research business of Thermo Fisher Scientific Inc. has unveiled a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
The new 72,500-square-foot building increases the site’s chemistry, manufacturing and control (CMC) analytical capabilities as part of its clinical development and laboratory services focused on improving health by helping customers deliver life-changing medicines.
“As research in biopharmaceutical therapies continues to rapidly expand, we are excited to expand our overall capacity and capabilities in laboratory services to help our customers deliver therapies that meet the highest quality and safety standards for patients,” said Leon Wyszkowski, president, analytical services, clinical research, Thermo Fisher Scientific. “This $58 million investment to expand the site is a testament to our dedication in supporting Thermo Fisher’s Mission of making the world healthier, cleaner and safer.”...
The new 72,500-square-foot building increases the site’s chemistry, manufacturing and control (CMC) analytical capabilities as part of its clinical development and laboratory services focused on improving health by helping customers deliver life-changing medicines.
“As research in biopharmaceutical therapies continues to rapidly expand, we are excited to expand our overall capacity and capabilities in laboratory services to help our customers deliver therapies that meet the highest quality and safety standards for patients,” said Leon Wyszkowski, president, analytical services, clinical research, Thermo Fisher Scientific. “This $58 million investment to expand the site is a testament to our dedication in supporting Thermo Fisher’s Mission of making the world healthier, cleaner and safer.”...
Share this article on you social outlets
Our Sponsors
- - Volume: 24 - WEEK: 25 Date: 6/20/2024 12:00:19 PM -